FRANK E. THOMAS - 09 Feb 2023 Form 4 Insider Report for Orchard Therapeutics plc

Role
Title: President & Chief Operating Officer
Signature
/s/ Frank Thomas
Issuer symbol
N/A
Transactions as of
09 Feb 2023
Net transactions value
+$9,182
Form type
4
Filing time
13 Feb 2023, 07:09:59 UTC
Previous filing
06 Oct 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORTX Ordinary Shares Options Exercise $9,182 +20,000 +38% $0.4591 72,081 09 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Options Exercise $0 -20,000 -5.3% $0.000000 355,000 09 Feb 2023 Ordinary Shares 20,000 $0.4591 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The shares subject to this option vest and become exercisable in twenty-four (24) equal monthly installments, with the first installment vested on March 1, 2022.

Remarks:

Title: President & Chief Operating Officer